Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness

Cited by (1,628)

Items 701–800 of 1,628

1. Clinical, immunological and bacteriological characteristics of H7N9 patients nosocomially co-infected by Acinetobacter Baumannii: a case control study
   William J. Liu, Rongrong Zou, Yongfei Hu, Min Zhao, Chuansong Quan, Shuguang Tan, Kai Luo, Jing Yuan, Haixia Zheng, Jue Liu et al. · 2018 · BMC Infectious Diseases
2. Invasive Salmonella Enteritidis infection complicated by bacterial meningitis and vertebral osteomyelitis shortly after influenza A infection in an immunocompetent young adult
   Kaoru Ikejiri, Kei Suzuki, Asami Ito, Kazunari Yasuda, Akihiro Shindo, Ken Ishikura, Hiroshi Imai · 2019 · Journal of Infection and Chemotherapy
3. The pneumococcal two-component system SirRH is linked to enhanced intracellular survival of Streptococcus pneumoniae in influenza-infected pulmonary cells
   Nicolás M. Reinoso-Vizcaíno, Melina B. Cian, Paulo R. Cortes, Nadia B. Olivero, Mirelys Hernandez-Morfa, Germán E. Piñas, Chandan Badapanda, Ankita Rathore, Daniel Roberto Perez, José Echenique · 2020 · PLoS Pathogens
4. Arbidol targeting influenza virus A Hemagglutinin; A comparative study
   Alhassan Ali Ahmed, Mohamed Abouzid · 2021 · Biophysical Chemistry
5. Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19
   Jordan J. Clark, Rebekah Penrice-Randal, Parul Sharma, Anja Kipar, Xiaofeng Dong, Shaun H. Pennington, Amy E. Marriott, Stefano Colombo, A DAVIDSON, Maia Kavanagh Williamson et al. · 2024 · Viruses
6. Benefit of Conjugate Pneumococcal Vaccination in Preventing Influenza Hospitalization in Children
   Fabiola Domínguez, Jesús Castilla, Pere Godoy, Miguel Delgado‐Rodríguez, Marc Sáez, Núria Soldevila, Jenaro Astray, José María Mayoral, Vicente Martín, José María Quintana et al. · 2013 · The Pediatric Infectious Disease Journal
7. Recent Changes in the Epidemiology of Group A Streptococcus Infections: Observations and Implications
   Susanna Esposito, Marco Masetti, Carolina Calanca, Nicolò Canducci, Sonia Rasmi, Alessandra Fradusco, Nicola Principi · 2025 · Microorganisms
8. Case 23-2020: A 76-Year-Old Woman Who Died from Covid-19
   James R. Stone, Kathy M. Tran, John Conklin, Mari A. Mino-Kenudson · 2020 · New England Journal of Medicine
9. Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology
   Lona Mody, Ibukunoluwa Akinboyo, Hilary M. Babcock, Werner E. Bischoff, Vincent Chi‐Chung Cheng, Kathleen Chiotos, Kimberly C. Claeys, Kelly Coffey, Daniel J. Diekema, Curtis J. Donskey et al. · 2021 · Infection Control and Hospital Epidemiology
10. RETROSPECTIVE ANALYSIS OF CORONAVIRUS DISEASE LETHAL CASES
    Е. О. Кіндратів, Volodymyr M. Vasylyk, V. M. Matskevych, В. М. Костюк, Владислав Семченко, Vitalii Voronych · 2021 · Fìzìologìčnij žurnal
11. Understanding the Present Through the Past: A Comparison of Spanish News Coverage of the 1918 Flu and COVID-19 Pandemics
    S. Edwards · 2021 · Journalism & Mass Communication Quarterly
12. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review
    Naveed Nazir Shah, Zaid Khan, Hashim Ahad, Abozer Y. Elderdery, Mohammad N. Alomary, Banan Atwah, Zain Alhindi, Mahdi H. Alsugoor, Ahmed M. E. Elkhalifa, Showkat Ul Nabi et al. · 2022 · Journal of Infection and Public Health
13. Roles and Mechanisms of NLRP3 in Influenza Viral Infection
    Junling Niu, Guangxun Meng · 2023 · Viruses
14. Overview/reflections on the 2009 H1N1 pandemic
    Surinder Pada, Paul Anantharajah Tambyah · 2011 · Microbes and Infection
15. Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons
    Fabiola Domínguez, Jesús Castilla, Pere Godoy, Miguel Delgado‐Rodríguez, Marc Sáez, Núria Soldevila, Jenaro Astray, José María Mayoral, Vicente Martín, José María Quintana et al. · 2013 · Human Vaccines & Immunotherapeutics
16. Hospitalized children with 2009 influenza a (H1N1) infection in Shenzhen, China, november–december 2009
    Yuejie Zheng, Yanxia He, Jikui Deng, Zhiwei Lu, Ju-Rong Wei, Weiguo Yang, Zhengzhen Tang, Boning Li, Jaosheng Zhang, Li Wang et al. · 2010 · Pediatric Pulmonology
17. SYNDEMICS OF WAR: MALNUTRITION‐INFECTIOUS DISEASE INTERACTIONS AND THE UNINTENDED HEALTH CONSEQUENCES OF INTENTIONAL WAR POLICIES
    Bayla M. M. Ostrach, Merrill C. Singer · 2012 · Annals of Anthropological Practice
18. Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection
    Sean Roberts, Sharon L. Salmon, Donald J. Steiner, Clare M. Williams, Dennis W. Metzger, Yoichi Furuya · 2019 · mBio
19. Predictors of Influenza Diagnosis Among Patients With Laboratory-Confirmed Influenza
    Marc R. Miller, Timothy R. Peters, Cynthia K. Suerken, Beverly Snively, Katherine A. Poehling · 2015 · The Journal of Infectious Diseases
20. Impact of Type I and III Interferons on Respiratory Superinfections Due to Multidrug-Resistant Pathogens
    Dane Parker · 2016 · The Journal of Infectious Diseases
21. Sequential infection with influenza A virus followed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) leads to more severe disease and encephalitis in a mouse model of COVID-19
    Jordan J. Clark, Rebekah Penrice-Randal, Parul Sharma, Anja Kipar, Xiaofeng Dong, Shaun H. Pennington, Amy E. Marriott, Stefano A. P. Colombo, Andrew D. Davidson, Maia Kavanagh Williamson et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
22. Synthetic Peptide Derived from Scorpion Venom Displays Minimal Toxicity and Anti-infective Activity in an Animal Model
    Cyntia Silva Oliveira, Marcelo D. T. Torres, Cibele Nicolaski Pedron · 2021 · ACS Infectious Diseases
23. The Contribution of Viral Proteins to the Synergy of Influenza and Bacterial Co-Infection
    Miriam Mikušová, Karolína Tomčíková, Katarína Briestenská, František Kostolanský, Eva Varečková · 2022 · Viruses
24. Host and microbiome features of secondary infections in lethal covid-19
    Martin Zacharias, Karl Kashofer, Philipp Wurm, Peter Regitnig, Moritz Schütte, Margit Neger, Sandra Ehmann, Leigh Matthew Marsh, Grażyna Kwapiszewska, Martina Loibner et al. · 2022 · iScience
25. Roles for Pathogen Interference in Influenza Vaccination, with Implications to Vaccine Effectiveness (VE) and Attribution of Influenza Deaths
    Rod Jones, Andrey Ponomarenko · 2022 · Infectious Disease Reports
26. Impact of the COVID-19 pandemic on non-COVID-19 community-acquired pneumonia: a retrospective cohort study
    Terry Lee, Keith R. Walley, John H. Boyd, Kelly A. Cawcutt, André C. Kalil, James A. Russell · 2023 · BMJ Open Respiratory Research
27. Impact of 13-valent pneumococcal conjugate vaccine (PCV13) in a pandemic similar to the 2009 H1N1 in the United States
    Lisa J. McGarry, Kristen E. Gilmore, Jaime L. Rubin, Keith P. Klugman, David R. Strutton, Milton C. Weinstein · 2013 · BMC Infectious Diseases
28. Severe Group A Streptococcal Infections
    Dennis Leroy Stevens, Amy Evelyn Bryant · 2016 · Europe PMC (PubMed Central)
29. Peripheral Leukocyte Migration in Ferrets in Response to Infection with Seasonal Influenza Virus
    Nedzad Music, Adrian J. Reber, Jin Hyang Kim, Ian A. York · 2016 · PLoS ONE
30. RSV Infection in Human Macrophages Promotes CXCL10/IP-10 Expression during Bacterial Co-Infection
    Daniela Bandeira Brancante Machado, Jonathan Hoffmann, Marie Moroso, Manuel Rosa‐Calatrava, Hubert P. Endtz, Olivier Terrier, Gláucia Paranhos‐Baccalà · 2017 · International Journal of Molecular Sciences
31. Investing in antibiotics to alleviate future catastrophic outcomes: What is the value of having an effective antibiotic to mitigate pandemic influenza?
    Itamar Megiddo, Dušan Drábik, Tim Bedford, Alec Morton, Justus Wesseler, Ramanan Laxminarayan · 2019 · Health Economics
32. Seasonal influenza-associated intensive care unit admission and death in tropical Singapore, 2011-2015
    Zoe X.Z. Zhang, Win Mar Kyaw, Hanley Jian An Ho, Min Zhi Tay, Hongjie Huang, Aung Aung Hein, Angela LP Chow · 2019 · Journal of Clinical Virology
33. Defusing COVID-19: Lessons Learned from a Century of Pandemics
    Graciela Mujica, Zane Sternberg, Jamie Solis, Taylor Wand, Peter Carrasco, Andrés F. Henao‐Martínez, Carlos Franco‐Paredes · 2020 · Tropical Medicine and Infectious Disease
34. The microbiota-related coinfections in COVID-19 patients: a real challenge
    Ranjan K. Mohapatra, Kuldeep Dhama, Snehasish Mishra, Ashish Kumar Sarangi, Venkataramana Kandi, Ruchi Tiwari, Lucia Pintilie · 2021 · Beni-Suef University Journal of Basic and Applied Sciences
35. Effects of Cigarette Smoking on Influenza Virus/Host Interplay
    Jerald Chavez, Rong Hai · 2021 · Pathogens
36. Bacteria and the growing threat of multidrug resistance for invasive cardiac interventions
    Grant N. Pierce, Craig T. Resch, Muntahi Mourin, Pavel A. Dibrov, Elena Dibrov, Amir Ravandi · 2022 · Reviews in Cardiovascular Medicine
37. Streptococcus pneumoniae
    Daniel M. Musher · 2010 · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
38. The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months.
    Carlos del Rı́o, Jeannette Guarner · 2010 · PubMed Central
39. The human microbiota: a new direction in the investigation of thoracic diseases.
    Anselm Wang Hei Hui, Hon-Wai Lau, Tiffany Hoi-Tung Chan, Stephen Kwok‐Wing Tsui · 2013 · Europe PMC (PubMed Central)
40. Radiographic study of severe Influenza-A (H1N1) disease in children
    Cailei Zhao, Yungen Gan, Jie Sun · 2010 · European Journal of Radiology
41. An Inception Cohort Study Assessing the Role of Pneumococcal and other Bacterial Pathogens in Children with Influenza and ILI and a Clinical Decision Model for Stringent Antibiotic Use
    Franziska Tief, Christian Hoppe, Lea Seeber, Patrick Obermeier, Xi Chen, Katharina Karsch, Susann Muehlhans, Eleni Adamou, Tim Conrad, Ariel Béresniak et al. · 2015 · Antiviral Therapy
42. Individual-level Association of Influenza Infection With Subsequent Pneumonia: A Case-control and Prospective Cohort Study
    John Kubale, Guillermina M. Kuan, Lionel Gresh, Sergio Ojeda, Amy J. Schiller, Nery Sánchez, Roger López, Eduardo Azziz‐Baumgartner, Steph Wraith, Eva Harris et al. · 2020 · Clinical Infectious Diseases
43. Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A H1N1 2009 infection in South Korea
    Shin Na, Mi‐Na Kim, Won‐Young Kim, Won Bae Kim, Sang‐Bum Hong, Chae‐Man Lim, Younsuck Koh, Ji‐Won Kwon, Soo‐Jong Hong, Sang‐Oh Lee et al. · 2010 · Scandinavian Journal of Infectious Diseases
44. Influenza and respiratory syncytial virus are the major respiratory viruses detected from prospective testing of pediatric and adult coronial autopsies
    David John Speers, Daniel M. Moss, Cara A Minney-Smith, Avram Levy, David W. Smith · 2013 · Influenza and Other Respiratory Viruses
45. The Effect of Intravenous Peramivir, Compared with Oral Oseltamivir, on the Outcome of Post-Influenza Pneumococcal Pneumonia in Mice
    Akitaka Tanaka, Shigeki Nakamura, Masafumi Seki, Naoki Iwanaga, Toshiki Kajihara, Mitsutaka Kitano, Tomoyuki Homma, Shintaro Kurihara, Yoshifumi Imamura, Taiga Miyazaki et al. · 2014 · Antiviral Therapy
46. Development of secondary bacterial pneumonia in adults presenting with influenza versus noninfluenza viral respiratory infection
    Kathryn H. Melamed, Justin Williams, Xiaoyan Wang, Scott B. Hu, Christopher D. Nguyen, Jing Cui, Jane C. Deng · 2020 · Therapeutic Advances in Respiratory Disease
47. Streptococcus pneumoniae and Influenza A Virus Co-Infection Induces Altered Polyubiquitination in A549 Cells
    Thomas Sura, Vanessa Gering, Clemens Cammann, Sven Hammerschmidt, Sandra Maaß, Ulrike Seifert, Dörte Becher · 2022 · Frontiers in Cellular and Infection Microbiology
48. Microbial and Immune Regulation of the Gut-Lung Axis during Viral-Bacterial Coinfection
    Sidney Lane, Yasmin Hilliam, Jennifer M. Bomberger · 2022 · Journal of Bacteriology
49. Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU)
    Raja Dhar, John Kirkpatrick, Laura Gilbert et al. · 2023 · PLoS ONE
50. Influenza A–induced cystic fibrosis transmembrane conductance regulator dysfunction increases susceptibility to Streptococcus pneumoniae
    Erin Y. Earnhardt, Jennifer L. Tipper, Adonis D’Mello, Ming‐Yuan Jian, Elijah S. Conway, James A. Mobley, Carlos Javier Orihuela, Hervé Tettelin, Kevin S. Harrod · 2023 · JCI Insight
51. Influenza A virus selectively elevates prostaglandin E2 formation in pro-resolving macrophages
    Paul Mike Jordan, Kerstin Günther, Vivien Nischang, Yuping Ning, Stefanie Deinhardt‐Emmer, Christina Ehrhardt, Oliver Werz · 2023 · iScience
52. Diverging patterns in innate immunity against respiratory viruses during a lifetime: lessons from the young and the old
    Hermelijn H. Smits, Simon P. Jochems · 2024 · European Respiratory Review
53. Microbial dynamics and pulmonary immune responses in COVID-19 secondary bacterial pneumonia
    Natasha Spottiswoode, Alexandra Tsitsiklis, Victoria T. Chu, Hoang Van Phan, Catherine DeVoe, Christina Love, Rajani Ghale, Joshua Daniel Bloomstein, Beth Shoshana Zha, Cole P. Maguire et al. · 2024 · Nature Communications
54. Amelioration of pneumonia with Streptococcus pneumoniae infection by inoculation with a vaccine against highly pathogenic avian influenza virus in a non‐human primate mixed infection model
    Taichiro Miyake, Kosuke Soda, Yasushi Itoh, Yoshihiro Sakoda, Hirohito Ishigaki, Tomoya Nagata, Hideaki Ishida, Misako Nakayama, Hiroichi Ozaki, Hideaki Tsuchiya et al. · 2009 · Journal of Medical Primatology
55. Guidelines on Management of Human Infection with the Novel Virus Influenza A (H1N1) – A Report from the Hospital das Clínicas of the University of São Paulo
    Ludhmila Abrahão Hajjar, Denise Schout, Filomena Regina Barbosa Gomes Galas, David Éverson Uip, Anna Sara Levin, Hélio Caiaffa-Filho, Pedro Takanori Sakane, Carlos Alberto Suslik, José Manoel de Camargo Teixeira, Eloísa Bonfá et al. · 2009 · Clinics
56. The problem of bacterial complications post respiratory viral infections
    Andrej Egorov · 2018 · Microbiology Independent Research Journal (MIR Journal)
57. Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections
    Miriam Klausberger, Ирина Анатольевна Ленева, Andrej Egorov, Florian Strobl, Sahar Masoumeh Ghorbanpour, Irina N. Falynskova, А. В. Поддубиков, Nailya R. Makhmudova, Artem Krokhin, О. А. Свитич et al. · 2019 · Vaccine
58. Viral pneumonia: a new look at an old problem (review)
    Харитонов Михаил Анатольевич, В. В. Салухов, Evgeniy V. Kryukov, Паценко Михаил Борисович, Yu. V. Rudakov, Аlexey B. Bogomolov, Vladimir V. Ivanov, Alexey A. Minakov · 2021 · Meditsinskiy sovet = Medical Council
59. The Severity of the Co-infection of Mycoplasma pneumoniae in COVID-19 Patients
    Rohit Rangroo, Myles Young, Alexander P. Davis, Steven Pack, Shaival Thakore, Anna Schepcoff, Olu Oyesanmi · 2022 · Cureus
60. Molecular Characterization of Staphylococcus aureus and Influenza Virus Coinfections in Patients with Fatal Pneumonia
    Amy M. Denison, Marlene DeLeon-Carnes, Dianna M. Blau, Eric C. Shattuck, Linda K. McDougal, James Kamile Rasheed, Brandi M. Limbago, Sherif R. Zaki, Christopher D. Paddock · 2013 · Journal of Clinical Microbiology
61. Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice
    Hirokazu Ezoe, Yukihiro Akeda, Zhenyu Piao, Taiki Aoshi, Shohei Koyama, Takeshi Tanimoto, Ken J. Ishii, Kazunori Oishi · 2011 · Vaccine
62. Was Bacterial Pneumonia the Predominant Cause of Death in the 1918–1919 Influenza Pandemic?
    David S. Fedson · 2009 · The Journal of Infectious Diseases
63. Chemical Oxygen Generation
    Kevin R. Ward, Gary S. Huvard, Mark A. McHugh · 2013 · Respiratory Care
64. Lower respiratory tract infection in cynomolgus macaques (Macaca fascicularis) infected with group A Streptococcus
    Randall J. Olsen, Madiha Ashraf, Vedia E. Gonulal, Ara A. Ayeras, Concepcion C. Cantu, Patrick R. Shea, Ronan K. Carroll, Tammy L. Humbird, Jamieson L. Greaver, Jody L. Swain et al. · 2010 · Microbial Pathogenesis
65. An Historical Antecedent of Modern Guidelines for Community Pandemic Influenza Mitigation
    David Michael Morens, Jeffery K. Taubenberger, Gregory K. Folkers, Anthony S. Fauci · 2009 · Public Health Reports
66. Influenza in High-Risk Hosts—Lessons Learned from Animal Models
    Rebekah Honce, Nicholas Wohlgemuth, Victoria Meliopoulos, Kirsty Renfree Short, Stacey Schultz‐Cherry · 2019 · Cold Spring Harbor Perspectives in Medicine
67. Molecular Biomarkers for Ancient Tuberculosis
    Edeani Bobby David, Oona Y-C., Houdini H.T., S. Gurdyal, Helen D. Donoghue · 2012 · InTech eBooks
68. Coinfection With Influenza A Virus and Klebsiella oxytoca: An Underrecognized Impact on Host Resistance and Tolerance to Pulmonary Infections
    Kayla M. Lee, Jenna Morris‐Love, Damien J. Cabral, Peter A. Belenky, Steven M. Opal, Amanda Mercedes Jamieson · 2018 · Frontiers in Immunology
69. COVID-19 versus the 1918 influenza pandemic: different virus, different age mortality patterns
    G. Dennis Shanks · 2020 · Journal of Travel Medicine
70. Antibiotic therapy for bacterial pneumonia
    Hideo Kato · 2024 · Journal of Pharmaceutical Health Care and Sciences
71. Novel findings from the second wave of adult pH1N1 in the United States*
    Lewis G. Satterwhite, Ashish Mehta, Greg S. Martin · 2010 · Critical Care Medicine
72. Retrospective analysis of necropsy findings in patients of H1N1 and their correlation to clinical features.
    Haridas B. Prasad, Shaila Chandrakant Puranik, D B Kadam, Shashi Sangle, Rohidas T. Borse, Anita Basavraj, P. B. Umarji, Vidya Mave, Shivhari Ghorpade, Renu Satish Bharadwaj et al. · 2011 · PubMed
73. Increase of Apoptosis in a Murine Model for Severe Pneumococcal Pneumonia during Influenza A Virus Infection
    Kosuke Kosai, Masafumi Seki, Akitaka Tanaka, Yoshitomo Morinaga, Yoshifumi Imamura, Koichi Izumikawa, Hiroshi Kakeya, Yoshihiro Yamamoto, Katsunori Yanagihara, Kazunori Tomono et al. · 2011 · Japanese Journal of Infectious Diseases
74. Staphylococcus aureus triggers a shift from influenza virus–induced apoptosis to necrotic cell death
    Andre van Krüchten, Janine J. Wilden, Silke Niemann, Georg Peters, Bettina Löffler, Stephan Ludwig, Christina Ehrhardt · 2018 · The FASEB Journal
75. The 1918 influenza pandemic did not accelerate tuberculosis mortality decline in early‐20th century Newfoundland: Investigating historical and social explanations
    Taylor P. van Doren, Lisa Sattenspiel · 2021 · American Journal of Physical Anthropology
76. Pro-resolving therapies as potential adjunct treatment for infectious diseases: Evidence from studies with annexin A1 and angiotensin-(1-7)
    Luciana P. Tavares, Eliza Mathias Melo, Lirlandia Pires Sousa, Mauro Martins Teixeira · 2022 · Seminars in Immunology
77. Antibiotics Use in Hospitalised COVID-19 Patients in a Tertiary Care Centre: A Descriptive Cross-sectional Study
    Bibechan Thapa, Samyam Bickram Pathak, Nisha Jha · 2022 · Journal of Nepal Medical Association
78. Metabolic conversion of CI-1040 turns a cellular MEK-inhibitor into an antibacterial compound
    Christin Bruchhagen, Marcel Jarick, Carolin Mewis, Tobias Hertlein, Silke Niemann, Knut Ohlsen, Georg Peters, Oliver Planz, Stephan Ludwig, Christina Ehrhardt · 2018 · Scientific Reports
79. Double-Edged Role of Interleukin 17A in Streptococcus pneumoniae Pathogenesis During Influenza Virus Coinfection
    Ganesh Ambigapathy, Taylor Schmit, Ramkumar Mathur, Suba Nookala, Saad Bahri, Liise‐anne Pirofski, M. Nadeem Khan · 2019 · The Journal of Infectious Diseases
80. Streptococcus pneumoniae (Pneumococcus)
    Timothy R. Peters, Jon S. Abramson · 2011 · Elsevier eBooks
81. Ratiometric Dual-Response Quantum Dot Spherical Nucleic Acid for Monitoring Viral Secondary Bacterial Infections
    Ai-Xin Ma, Leping Lin, Qing Zhang, Ming‐Yu Zhang, Lin‐Han Jiang, Jiaxuan Chen, Shu‐Lin Liu, Zhi‐Gang Wang, Dai‐Wen Pang · 2025 · Analytical Chemistry
82. Aggravated MRSA pneumonia secondary to influenza A virus infection is derived from decreased expression of IL‐1β
    Yunfeng Shi, Xiaohan Shi, Jingjing Liang, Jinmei Luo, Junhui Ba, Jianning Chen, Benquan Wu · 2020 · Journal of Medical Virology
83. COVID-19 Autopsies Reveal Underreporting of SARS-CoV-2 Infection and Scarcity of Co-infections
    Nathalie Schwab, Ronny Nienhold, Maurice Henkel, Albert Baschong, Anne Graber, Angela Frank, Nadine Mensah, Jacqueline Koike, Claudia Hernach, Melanie Sachs et al. · 2022 · Frontiers in Medicine
84. Comparative Pathology of Animal Models for Influenza A Virus Infection
    Natalie M. Kirk, Yuying Liang, Hinh Ly · 2023 · Pathogens
85. A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection
    Saugata Majumder, Peng Li, Shreya Das, Tanvir Noor Nafiz, Sudeep Kumar, Guangchun Bai, Hazel Dellario, Haixin Sui, Ziqiang Guan, Roy Curtiss et al. · 2024 · Mucosal Immunology
86. Viral Pneumonia: From Influenza to COVID-19
    Catia Cillóniz, Guinevere N. Dy-Agra, Rodolfo S. Pagcatipunan, Antoní Torres · 2024 · Seminars in Respiratory and Critical Care Medicine
87. Sinensetin attenuates LPS-induced acute pulmonary inflammation in mice and RAW264.7 cells by modulating NF-κB p65-mediated immune resistance and STAT3-mediated tissue resilience
    Zaibin Xu, Kongyan Wang, Huiyu Hu, Yingjie Hu, Yingjie Hu, Zhuohui Luo · 2025 · International Immunopharmacology
88. Economics of stockpiling for an influenza pandemic
    Praveen Dhankhar, Erik J. Dasbach, Elamin H. Elbasha · 2009 · The Lancet Infectious Diseases
89. Empirical treatment of influenza-associated pneumonia in primary care: a descriptive study of the antimicrobial susceptibility of lower respiratory tract bacteria (England, Wales and Northern Ireland, January 2007-March 2010)
    Ruth Marion Blackburn, Katherine L. Henderson, M. Lillie, Elizabeth A. S. Sheridan, R.C. George, A. H. B. Deas, Alan P. Johnson · 2011 · Thorax
90. Histone Deacetylase Inhibition Protects Mice Against Lethal Postinfluenza Pneumococcal Infection
    Kazuma Yagi, Makoto Ishii, Ho Namkoong, Hideki Fujii, Takahiro Asami, Shoji Suzuki, Takanori Asakura, Kosuke Mizoguchi, Tetsuro Kamo, Sadatomo Tasaka et al. · 2016 · Critical Care Medicine
91. The endotoxin-induced pulmonary inflammatory response is enhanced during the acute phase of influenza infection
    Rebecca M. Koch, Dimitri Adriaan Diavatopoulos, Gerben Ferwerda, Peter Pickkers, Marien Isaäk de Jonge, Matthijs Kox · 2018 · Intensive Care Medicine Experimental
92. Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker
    Cristina Vazquez Guillamet, Hrishikesh S. Kulkarni, Kevin Montes, Maanasi Samant, Preet Ayoub Shaikh, Kevin D. Betthauser, Philip A. Mudd, Daniel Reynolds, Jane A. O’Halloran, Patrick G. Lyons et al. · 2021 · Critical Care Explorations
93. Exebacase Is Active In Vitro in Pulmonary Surfactant and Is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung Infection
    Steven M. Swift, Karen Sauve, Cara Cassino · 2021 · Antimicrobial Agents and Chemotherapy
94. Identifying Risk Factors for Secondary Infection Post-SARS-CoV-2 Infection in Patients With Severe and Critical COVID-19
    Mingquan Guo, Menglu Gao, Jing Gao, Téngfēi Zhāng, Xin Jin, Jian‐Gao Fan, Qianying Wang, Xin Li, Jian Chen, Zhaoqin Zhu · 2021 · Frontiers in Immunology
95. Infection metallomics for critical care in the post‐COVID era
    Rutuja H. Patil, Dominika Luptáková, Vladimı́r Havlı́ček · 2021 · Mass Spectrometry Reviews
96. Klebsiella pneumoniae infection following H9N2 influenza A virus infection contributes to the development of pneumonia in mice
    Li Li-juan, Kang Shun, Zhijuan Li, Dan Li, Xiao Ning Feng, Yuan Peng, Zhang Bo-shun, Shijin Jiang, Zhijing Xie · 2021 · Veterinary Microbiology
97. Mucormycosis of the bones of the facial skull, nasal cavity and par anasal sinuses in patients with COVID19
    Irina B. Baranova, Andrey I. Yaremenko, А.А. Зубарева, Sergei A. Karpischenko, Marina Olegovna Popova, Anton A. Kurus, Портнов Глеб Валерьевич, O. N. Pinegina, Лукина Ольга Васильевна, M. V. Malyarevskaya et al. · 2021 · Clinical Microbiology and Antimicrobial Chemotherapy
98. Healthcare-associated infections: a threat to the survival of patients with COVID-19 in intensive care units
    Viviane de Macedo, Gabryella S. P. Santos, R.N. Silva et al. · 2022 · Journal of Hospital Infection
99. Type I IFN Signaling Is Essential for Preventing IFN-γ Hyperproduction and Subsequent Deterioration of Antibacterial Immunity during Postinfluenza Pneumococcal Infection
    Sunil Palani, Shruti Bansal, Atul K Verma, Christopher D. Bauer, Shengjun Shao, Md Bashir Uddin, Keer Sun · 2022 · The Journal of Immunology
100. Increased virus dissemination leads to enhanced lung injury but not inflammation during influenza-associated secondary bacterial infection
     Amanda Pfaff Smith, Lindey C. Lane, Ivan Ramirez-Zuniga, David J. Moquin, Peter Vogel, Amber M Smith · 2022 · FEMS Microbes